St. Olavs hospital HF

Trondheim NO-7030

1 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type 2, Diffuse Large B-cell Lymphoma, Malignant Melanoma, Multiple Myeloma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
• UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma — Completed